Citius Pharmaceuticals, Inc. Stock Repurchase Program, Remaining Number of Shares Authorized to be Repurchased
Citius Pharmaceuticals, Inc. (CTXR) had Stock Repurchase Program, Remaining Number of Shares Authorized to be Repurchased of 35.00 thousand shares as of 2022-12-31, per its 10-Q filed 2023-02-10.
Discontinued › Notes › Equity
us-gaap:StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased · last filed 2023-02-10
- 2022-12-31: Stock Repurchase Program, Remaining Number of Shares Authorized to be Repurchased 35.00K shares.
| Period end | Stock Repurchase Program, Remaining Number of Shares Authorized to be Repurchased |
|---|---|
| 2022-12-31 | 35.00K shares 10-Q · filed 2023-02-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |